Impact of ganciclovir prophylaxis on heart-lung and lung transplant recipients

Journal of Heart and Lung Transplantation

Volumn 15, Issue 9, 1996, Pages 881-887

  Soghikian, M V ^a   Valentine, V G ^a   Berry, G J ^a   Patel, H R ^a   Robbins, R C ^a   Theodore, J ^a  

^a SCRIPPS CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GANCICLOVIR; PREDNISONE;

ADOLESCENT; ADULT; AGED; ARTICLE; BRONCHIOLITIS; CHILD; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DOSE RESPONSE; FEMALE; GRAFT REJECTION; HEART LUNG TRANSPLANTATION; HUMAN; INFECTION CONTROL; INTRAVENOUS DRUG ADMINISTRATION; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; RESPIRATORY FAILURE; TREATMENT OUTCOME; VIRUS PNEUMONIA;

ADOLESCENT; ADULT; ANTIVIRAL AGENTS; BRONCHIOLITIS OBLITERANS; CHILD; CYTOMEGALOVIRUS INFECTIONS; FEMALE; GANCICLOVIR; HEART-LUNG TRANSPLANTATION; HUMANS; INCIDENCE; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; PNEUMONIA, VIRAL; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0029741918     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)